Wolverine Blend 10mg
LOT 1001
>99.50%
HPLC purity · meets spec
- Labeled
- 5mg / 5mg
- Measured
- 5.19mg / 5.99mg
- Identity
- BPC-157 · TB-500
- Tested
- Jul 17, 2026
3 assays passed · ISO/IEC 17025 accredited
View certificate
Diluent Solution
3ml
$10.00
Regular price
$15.00
Sale price
$10.00
Skip to product information
Diluent Solution
$10.00
Regular price
$15.00
Sale price
$10.00
For research use only. Not for human consumption. Compassionate curators of fine peptides.
0.9% Benzyl Alcohol · Laboratory-Grade · Sterile Aqueous Preparation
Mollecule Diluent Solution is a laboratory-grade sterile aqueous preparation intended exclusively for analytical, sample preparation, and controlled research applications.
Formulated with 0.9% benzyl alcohol, each unit is prepared under aseptic conditions for use as a diluent or solvent in research and laboratory sample preparation workflows.
Product details:
• Product: Laboratory-Grade Diluent Solution
• Form: Sterile aqueous preparation
• Composition: 0.9% benzyl alcohol
• Volumes: 3ml and 10ml
• Storage: Store at controlled room temperature, away from direct light
• Intended use: Research and laboratory use only
For research purposes only. Not for human or veterinary use. Not for injection, infusion, or clinical application.
Related peptides
Third-party verified
Certificate of Analysis
Every lot is HPLC-tested at an ISO/IEC 17025-accredited lab. Open any batch’s certificate below.
Sources & References
Peer-reviewed research
-
NEW ENGLAND JOURNAL OF MEDICINE
Triple-Hormone-Receptor Agonist GLP-3 (RT) for Obesity - A Phase 2 Trial
View Source -
THE LANCET
GLP-3 (RT) for People with Type 2 Diabetes - A Phase 2 Trial
View Source -
NATURE MEDICINE
GLP-3 (RT) for Metabolic Dysfunction-Associated Steatotic Liver Disease
View Source -
LANCET DIABETES & ENDOCRINOLOGY
Effects of GLP-3 (RT) on Body Composition
View Source -
PUBMED CENTRAL
Triple Agonism Based Therapies for Obesity
View Source -
PUBMED CENTRAL
GLP-3 (RT) - A Game Changer in Obesity Pharmacotherapy
View Source -
PUBMED CENTRAL
Efficacy and Safety of GLP-3 (RT) - Systematic Review & Meta-Analysis
View Source -
ELI LILLY
TRIUMPH-4 Phase 3 Trial Results
View Source -
NATURE CELL DISCOVERY
Structural Analysis of Incretin Receptor Agonists
View Source -
PUBCHEM DATABASE
GLP-3 (RT) Compound Information
View Source -
CLINICALTRIALS.GOV
GLP-3 (RT) Clinical Trials Registry
View Source